Amazentis enters into strategic partnership with Nestlé Health Science

Nestlé Health Science will take an equity stake in Amazentis and received global rights to use Amazentis' patented Urolithin A, a promising anti-aging compound.

Kellerhals Carrard SA Lausanne/Sion (Jean-Luc Chenaux, partner, Stéphane Manaï, senior associate and Joséphine Marmy, associate) acted as legal advisor to Amazentis in this transaction.